Marinus Pharmaceuticals, Inc.
Ganaxolone for use in treatment of status epilepticus

Last updated:

Abstract:

This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.

Status:
Grant
Type:

Utility

Filling date:

26 Feb 2021

Issue date:

7 Sep 2021